Provided by Tiger Trade Technology Pte. Ltd.

Irhythm Technologies Inc.

128.52
+0.54000.42%
Post-market: 128.520.00000.00%19:30 EDT
Volume:451.64K
Turnover:57.94M
Market Cap:4.22B
PE:-299.11
High:129.66
Open:129.45
Low:125.73
Close:127.98
52wk High:212.00
52wk Low:100.85
Shares:32.85M
Float Shares:31.65M
Volume Ratio:0.73
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4297
EPS(LYR):-1.3920
ROE:-9.63%
ROA:0.65%
PB:22.70
PE(LYR):-92.32

Loading ...

iRhythm to Issue USD 50 Million in Unregistered Shares as Deal Consideration for VitalConnect Acquisition

Reuters
·
Aug 07

Irhythm Technologies Announces Acquisition of Vital Connect

TIPRANKS
·
Aug 07

iRhythm Technologies Q2 Swings to Earnings, Revenue Rises; Shares Gain

MT Newswires Live
·
Aug 07

iRhythm Holdings, Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Irhythm Technologies Boosts Outlook, Expands Cardiac Monitoring Platform

TIPRANKS
·
Aug 07

GUIDANCE: (IRTC) IRhythm Technologies Expects 2026 Revenue Range $880M - $890M, vs. FactSet Est of $881.1M

MT Newswires Live
·
Aug 07

iRhythm Agrees to Buy VitalConnect for $287.5 Million

Reuters
·
Aug 07

iRhythm Q2 Revenue Beats Estimates on Sustained Volume Demand, Lifts FY Guidance

Reuters
·
Aug 07

iRhythm - Co and Baxter Grant Each Other Royalty-Free Licenses for Cardiac Monitoring Sensor Patents - SEC Filing

THOMSON REUTERS
·
Aug 07

iRhythm - to Pay $50 Mln to Baxter in Patent Settlement - SEC Filing

THOMSON REUTERS
·
Aug 07

iRhythm Technologies Q2 Adj. EPS $0.58 Beats $(0.00) Estimate, Sales $224.172M Beat $219.324M Estimate

Benzinga Earnings
·
Aug 07

iRhythm Holdings Q2 Revenue USD 224.2 Million Vs. IBES Estimate USD 219.3 Million

Reuters
·
Aug 07

iRhythm to Acquire Vitalconnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care

THOMSON REUTERS
·
Aug 07

iRhythm Holdings, - Cash Portion of Deal to be Funded from Existing Cash

THOMSON REUTERS
·
Aug 07

iRhythm Holdings - Deal Expected to Enhance Co's Revenue Growth Rate from 2027 and Maintain 15% Adj Ebitda Margin Target for 2027

THOMSON REUTERS
·
Aug 07

iRhythm Holdings, - to Provide up to $30 Mln Interim Financing to Vitalconnect

THOMSON REUTERS
·
Aug 07

iRhythm Holdings, - Deal Valued at $287.50 Mln; $237.50 Mln Cash, $50 Mln Stock

THOMSON REUTERS
·
Aug 07

iRhythm Holdings Outlook FY Revenue USD 880-890 Million

THOMSON REUTERS
·
Aug 07

iRhythm Holdings Q2 Adjusted EPS USD 0.58

THOMSON REUTERS
·
Aug 07

Irhythm’s SHASTA II Update: What Zio’s 30-Day Wear Validation Means for IRTC Investors

TIPRANKS
·
Aug 06